Literature DB >> 12111447

Beta-CIT SPECT demonstrates reduced availability of serotonin transporters in patients with Fatal Familial Insomnia.

S Klöppel1, W Pirker, T Brücke, G G Kovács, G Almer.   

Abstract

Fatal familial insomnia (FFI) is a rare hereditary human prion disease with unique clinical features including progressive sleep impairment and autonomic dysfunction. The serotonergic system is considered to be involved in the regulation of the sleep-wake cycle. In this study we demonstrate a reduced availability of serotonin transporters of 57% and 73% respectively in a thalamus-hypothalamus region of two FFI patients examined with beta-CIT SPECT as compared to age-expected control values.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111447     DOI: 10.1007/s007020200093

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  4 in total

1.  [Fatal familial insomnia: case presentation and discussion of typical clinical and imaging findings].

Authors:  A V Thomas; J C Klein; A Brockhaus-Dumke; W D Heiss; A H Jacobs; H F Petereit
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

2.  A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease.

Authors:  Danielle Beckman; Rafael Linden
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

3.  Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.

Authors:  Sophie Mouillet-Richard; Noriyuki Nishida; Elodie Pradines; Hubert Laude; Benoît Schneider; Cécile Féraudet; Jacques Grassi; Jean-Marie Launay; Sylvain Lehmann; Odile Kellermann
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

4.  Fatal Familial Insomnia Initially Developing Parkinsonism Mimicking Dementia with Lewy Bodies.

Authors:  Takuya Fukuoka; Yoshihiko Nakazato; Masaomi Yamamoto; Akifumi Miyake; Takashi Mitsufuji; Toshimasa Yamamoto
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.